Observing disease progression in progeria patients
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This study follows patients with Hutchinson-Gilford progeria syndrome (a rare genetic condition that causes rapid aging in children) to track how the disease progresses over time. It aims to better understand the condition, which may help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of Hutchinson-Gilford progeria syndrome.
- The diagnosis must be confirmed by a specific genetic test (LMNA gene mutation c.1824C>T, p.G608G).
- There are no other restrictions for joining this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study takes a small blood sample from people with progeria and turns the blood cells into stem cells in the lab. These stem cells are then used to test potential medicines, which could help find better treatments for progeria.
This trial tests whether adding everolimus to ongoing lonafarnib improves health and slows complications in people with genetically confirmed progeria. It mainly checks safety and early signs of benefit in Phase I/II.
This study follows people of all ages with a confirmed POLG-related disease to learn how the condition changes over time. The information collected may help design better care and future treatments.
This study follows people who already have hypophosphatasia (HPP) to better understand how the condition changes over time. It may help doctors recognize patterns and improve care, even if you are not receiving a new treatment.
This study follows people with MPS IIIC over time to learn more about how the disease progresses. It does not test a new treatment, but the information may help with future care and research.
This study follows people who have von Hippel-Lindau (VHL) over time to better understand how the condition changes. It may help doctors plan future treatments by collecting long-term health information.
Hear when a new Hutchinson-Gilford Progeria Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.